查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762319

性传染病分子诊断市场，规模，占有率，趋势，产业分析报告:各产品，各用途，各技术，各地区，2025年～2034年的市场预测

Molecular Diagnostics For Sexually Transmitted Diseases Market Size, Share, Trends, & Industry Analysis Report By Product (Instruments & Services, Consumables, and Software), By Application, By Technology, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 123 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，全球性传染病分子诊断市场规模预计到 2034 年将达到 78.5 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

性传染病 (STD) 分子诊断采用先进的实验室技术，用于识别导致这些感染的微生物的遗传物质，例如 DNA 或 RNA。与抗体或培养液检测等传统方法不同，分子检测可以直接辨识病原体本身。这使得检测高度准确且灵敏，通常可以在感染早期或症状尚未出现时进行诊断。

随着全球性传染病的盛行率不断上升，性传染病分子诊断市场正在经历显着增长，这需要更有效、更快速的诊断解决方案来应对公共卫生课题。此外，分子检测技术的不断进步，例如能够同时检测多种病原体的多重检测方法的开发，正在提高检测效率和可及性。医疗保健专业人员和公众对早期准确性传播疾病诊断重要性的认识不断提高，也促进了这些先进诊断方法的普及。

性传染病分子诊断市场报告重点

按产品划分，包括试剂和试剂盒在内的耗材占据了最大的占有率，因为它们在任何性传染病分子检测中都发挥着至关重要的作用。

按应用划分，CT/NG 检测领域在 2024 年占据主导地位。

从技术角度来看，由于中心化实验室完善的基础设施，实验室检测领域在 2024 年占据最大占有率。

按地区划分，北美在 2024 年占据性传染病分子诊断市场的主导销售占有率。预计亚太地区将成为预测期内成长最快的地区。

市场主要参与者包括雅培实验室、罗氏诊断公司（罗氏诊断）、生物梅里埃公司、凯杰公司、豪洛捷公司、碧迪公司、西门子医疗公司、DiaSorin公司、赛默飞世尔科技公司、QuidelOrtho公司和Seegene公司。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 性传染病分子诊断的全球市场分析

  • 市场概述
  • 性传染病分子诊断市场动态
    • 促进因素和机会
      • 性传染感染发生率不断上升
      • 诊断工具的技术进步
    • 限制与课题
      • 诊断侦测与设备成本高昂
  • PESTEL分析
  • 性传染病分子诊断市场应用趋势
  • 价值链分析
  • COVID-19影响分析

第5章 性传染病分子诊断市场:各产品

  • 主要调查结果
  • 简介
  • 设备和服务
  • 消耗品
  • 软体

第6章 性传染病分子诊断市场:各用途

  • 主要调查结果
  • 简介
  • CT/NG检验
  • 梅毒检验
  • 淋病检验
  • HSV检验
  • HPV检验
  • HIV检验
  • 毛滴虫属
  • urea等离子+ 霉浆菌属
  • 其他

第7章 性传染病分子诊断的全球市场:各技术

  • 主要调查结果
  • 简介
  • 临床检验
  • PoC试验

第8章 性传染病分子诊断市场:各地区

  • 主要调查结果
  • 简介
    • 性传染病分子诊断市场评估:各地区，2020～2034年
  • 北美
    • 北美:各产品，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:各技术，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品，2020～2034年
    • 欧洲:各用途，2020～2034年
    • 欧洲:各技术，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品，2020～2034年
    • 亚太地区:各用途，2020～2034年
    • 亚太地区:各技术，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品，2020～2034年
    • 中东·非洲:各用途，2020～2034年
    • 中东·非洲:各技术，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各产品，2020～2034年
    • 南美:各用途，2020～2034年
    • 南美:各技术，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Abbott Laboratories
  • Becton, Dickinson and Company(BD)
  • bioMerieux SA
  • DiaSorin S.p. A.
  • F. Hoffmann-La Roche AG(Roche Diagnostics)
  • Hologic Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Seegene Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: PM5807

The global molecular diagnostics for sexually transmitted diseases market size is expected to reach USD 7.85 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Diagnostics for Sexually Transmitted Diseases Market Size, Share, Trends, & Industry Analysis Report By Product (Instruments & Services, Consumables, and Software), By Application, By Technology, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Molecular diagnostics for sexually transmitted diseases (STDs) involves advanced laboratory techniques that pinpoint the genetic material, such as DNA or RNA, of the microorganisms causing these infections. Unlike older methods that might look for antibodies or grown cultures, molecular tests directly identify the pathogen itself. This allows for highly accurate and sensitive detection, often enabling diagnosis even in the early stages of an infection or when symptoms are not yet present, which is crucial for timely treatment and preventing further spread.

The market for molecular diagnostics for STDs is experiencing significant growth due to the rising global incidence of STDs, which necessitates more effective and rapid diagnostic solutions to manage public health challenges. Additionally, ongoing technological advancements in molecular testing, including the development of multiplex assays that can detect multiple pathogens simultaneously, are enhancing testing efficiency and accessibility. The increasing awareness among healthcare professionals and the general public about the importance of early and accurate STD diagnosis also contributes to the expanding adoption of these advanced diagnostic methods.

Molecular Diagnostics for Sexually Transmitted Diseases Market Report Highlights:

By product, the consumables segment, encompassing reagents and kits, holds the largest share due to its essential role in every molecular STD test.

Based on application, the CT/NG testing segment dominated in 2024 as these are among the most prevalent STDs worldwide.

In terms of technology, the laboratory testing segment held the largest share in 2024, supported by the established infrastructure of centralized labs.

By region, North America dominated the molecular diagnostics for sexually transmitted diseases market revenue share in 2024. Asia Pacific is projected to witness the fastest growth during the forecast period.

A few key players in the market include Abbott Laboratories; F. Hoffmann-La Roche AG (Roche Diagnostics); bioMerieux SA; QIAGEN N.V.; Hologic Inc.; Becton, Dickinson and Company (BD); Siemens Healthineers AG; DiaSorin S.p.A.; Thermo Fisher Scientific Inc.; QuidelOrtho Corporation; and Seegene Inc.

Polaris Market Research has segmented the molecular diagnostics for sexually transmitted diseases market report on the basis of product, application, technology, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Instruments & Services

Consumables

Software

By Application Outlook (Revenue - USD Billion, 2020-2034)

CT/NG Testing

Syphilis Testing

Gonorrhea Testing

HSV Testing

HPV Testing

HIV Testing

Trichomonas

Ureaplasma + Mycoplasma

Others

By Technology Outlook (Revenue - USD Billion, 2020-2034)

Laboratory Testing

Commercial/Private Labs

Public Health Labs

PoC testing

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Insights

  • 4.1. Molecular Diagnostics For Sexually Transmitted Diseases Market - Market Snapshot
  • 4.2. Molecular Diagnostics For Sexually Transmitted Diseases Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Incidence of Sexually Transmitted Diseases
      • 4.2.1.2. Technological Advancements in Diagnostic Tools
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Diagnostic Tests and Equipment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Molecular Diagnostics For Sexually Transmitted Diseases Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Instruments & Services
    • 5.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Instruments & Services, by Region, 2020-2034 (USD Billion)
  • 5.4. Consumables
    • 5.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Consumables, by Region, 2020-2034 (USD Billion)
  • 5.5. Software
    • 5.5.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Software, by Region, 2020-2034 (USD Billion)

6. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • 6.3. CT/NG testing
    • 6.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by CT/NG testing, by Region, 2020-2034 (USD Billion)
  • 6.4. Syphilis testing
    • 6.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Syphilis testing, by Region, 2020-2034 (USD Billion)
  • 6.5. Gonorrhea testing
    • 6.5.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Gonorrhea testing, by Region, 2020-2034 (USD Billion)
  • 6.6. HSV testing
    • 6.6.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HSV testing, by Region, 2020-2034 (USD Billion)
  • 6.7. HPV testing
    • 6.7.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HPV testing, by Region, 2020-2034 (USD Billion)
  • 6.8. HIV testing
    • 6.8.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HIV testing, by Region, 2020-2034 (USD Billion)
  • 6.9. Trichomonas
    • 6.9.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Trichomonas, by Region, 2020-2034 (USD Billion)
  • 6.10. Ureaplasma + Mycoplasma
    • 6.10.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Ureaplasma + Mycoplasma, by Region, 2020-2034 (USD Billion)
  • 6.11. Others
    • 6.11.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. Laboratory Testing
    • 7.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Laboratory Testing, by Region, 2020-2034 (USD Billion)
    • 7.3.2. Commercial/Private Labs
    • 7.3.3. Public Health Labs
  • 7.4. PoC testing
    • 7.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by PoC testing, by Region, 2020-2034 (USD Billion)

8. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Molecular Diagnostics For Sexually Transmitted Diseases Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Molecular Diagnostics For Sexually Transmitted Diseases Market - North America
    • 8.3.1. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
    • 8.3.2. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - U.S.
      • 8.3.4.1. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - Canada
      • 8.3.5.1. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • 8.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - Europe
    • 8.4.1. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - UK
      • 8.4.4.1. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - France
      • 8.4.5.1. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Germany
      • 8.4.6.1. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Italy
      • 8.4.7.1. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.8. Molecular Diagnostics For Sexually Transmitted Diseases Market - Spain
      • 8.4.8.1. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.9. Molecular Diagnostics For Sexually Transmitted Diseases Market - Netherlands
      • 8.4.9.1. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.10. Molecular Diagnostics For Sexually Transmitted Diseases Market - Russia
      • 8.4.10.1. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.11. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • 8.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - Asia Pacific
    • 8.5.1. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - China
      • 8.5.4.1. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - India
      • 8.5.5.1. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Malaysia
      • 8.5.6.1. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Japan
      • 8.5.7.1. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.8. Molecular Diagnostics For Sexually Transmitted Diseases Market - Indonesia
      • 8.5.8.1. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.9. Molecular Diagnostics For Sexually Transmitted Diseases Market - South Korea
      • 8.5.9.1. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.10. Molecular Diagnostics For Sexually Transmitted Diseases Market - Australia
      • 8.5.10.1. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.11. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • 8.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - UAE
      • 8.6.5.1. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Israel
      • 8.6.6.1. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - South Africa
      • 8.6.7.1. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.8. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • 8.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Latin America
    • 8.7.1. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - Mexico
      • 8.7.4.1. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - Brazil
      • 8.7.5.1. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Argentina
      • 8.7.6.1. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company (BD)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. bioMerieux SA
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. DiaSorin S.p. A.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche AG (Roche Diagnostics)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hologic Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. QIAGEN N.V.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. QuidelOrtho Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Seegene Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Siemens Healthineers AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Thermo Fisher Scientific Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 4 North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 5 North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 7 U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 8 U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 10 Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 11 Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 13 Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 16 UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 17 UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 19 France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 20 France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 22 Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 23 Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 25 Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 28 Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 29 Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 34 Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 35 Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 43 China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 44 China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 46 India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 47 India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 52 Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 53 Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 58 South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 59 South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 61 Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 73 UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 74 UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 76 Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 77 Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 79 South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 80 South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 85 Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 88 Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 89 Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 91 Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 92 Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 94 Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 95 Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2024 & 2034 (USD Billion)